SILVERSTEIN JONATHAN
Insider CIK 1171005 · GKOS Director, 10% owner · ICPT Director, 10% owner · AVDR Director, 10% owner · RLYP Director, 10% owner · ROKA Director, 10% owner · SCPH Director · BOLD Director, 10% owner · RYTM Director · TORC Director, 10% owner · ARQT Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-10-02 | 2020-10-06 | 200,000 | $25.00 | $5.00M | 4,267,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-10-02 | 2020-10-06 | 296,000 | $25.00 | $7.40M | 902,286 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2020-02-27 | 2020-03-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 429,786 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 2,825,603 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 859,573 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 859,573 | — | $0 | 4,067,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 2,825,603 | — | $0 | 3,207,991 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 429,786 | — | $0 | 606,286 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-03 | 2020-02-04 | 176,500 | $17.00 | $3.00M | 176,500 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-03 | 2020-02-04 | 382,388 | $17.00 | $6.50M | 382,388 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-25 | 3,005 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-25 | 8,314 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | D To issuer | 2019-11-21 | 2019-11-25 | 4,240,128 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 3,370,786 | — | $0 | 3,523,204 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 383,746 | — | $0 | 4,240,128 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 333,178 | — | $0 | 3,856,382 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 20,114 | $30.77 | $618.9K | 46,676 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 886 | $30.01 | $26.6K | 637 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 93,008 | $30.01 | $2.79M | 66,790 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 445 | $32.06 | $14.3K | 0 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 192 | $30.77 | $5.9K | 445 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-06 | 2018-03-06 | 46,676 | $32.06 | $1.50M | 0 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-05 | 2018-03-06 | 768 | $33.06 | $25.4K | 1,523 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-05 | 2018-03-06 | 80,516 | $33.06 | $2.66M | 159,798 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-05 | 2018-03-06 | 128,092 | $32.05 | $4.11M | 240,314 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-05 | 2018-03-06 | 1,220 | $32.05 | $39.1K | 2,291 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-02 | 2018-03-06 | 1,851 | $32.80 | $60.7K | 3,511 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-02 | 2018-03-06 | 194,433 | $32.80 | $6.38M | 368,406 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-02 | 2018-03-06 | 2,533 | $31.92 | $80.9K | 5,362 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2018-03-02 | 2018-03-06 | 265,766 | $31.92 | $8.48M | 562,839 | SEC↗ |
| TORC resTORbio, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 2,425,482 | — | $0 | 0 | SEC↗ |
| TORC resTORbio, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 0 | SEC↗ |
| TORC resTORbio, Inc. | P Buy | 2018-01-30 | 2018-01-30 | 533,333 | $15.00 | $8.00M | 4,830,387 | SEC↗ |
| TORC resTORbio, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 1,871,569 | — | $0 | 4,297,054 | SEC↗ |
| TORC resTORbio, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 2,425,485 | — | $0 | 2,425,485 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2017-12-13 | 2017-12-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 18,500,000 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 2,576,532 | — | $0 | 2,576,532 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 553 | $40.77 | $22.5K | 7,895 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 173,349 | $37.94 | $6.58M | 1,076,444 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 1,651 | $37.94 | $62.6K | 10,256 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 189,792 | $39.63 | $7.52M | 886,652 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 58,047 | $40.77 | $2.37M | 828,605 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 1,808 | $39.63 | $71.7K | 8,448 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-01 | 2017-09-05 | 1,038 | $37.72 | $39.2K | 11,907 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-01 | 2017-09-05 | 109,040 | $37.72 | $4.11M | 1,249,793 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-31 | 2017-09-05 | 44,498 | $37.82 | $1.68M | 1,358,833 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-31 | 2017-09-05 | 424 | $37.82 | $16.0K | 12,945 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-17 | 2017-08-17 | 224,780 | $37.85 | $8.51M | 1,403,331 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-17 | 2017-08-17 | 2,140 | $37.85 | $81.0K | 13,369 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-16 | 2017-08-17 | 64,961 | $38.01 | $2.47M | 1,628,111 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-16 | 2017-08-17 | 619 | $38.01 | $23.5K | 15,509 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-15 | 2017-08-17 | 307 | $38.29 | $11.8K | 16,128 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-15 | 2017-08-17 | 32,193 | $38.29 | $1.23M | 1,693,072 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-14 | 2017-03-14 | 73,401 | $44.54 | $3.27M | 1,725,265 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-14 | 2017-03-14 | 699 | $44.54 | $31.1K | 16,435 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 1,998 | $45.30 | $90.5K | 17,141 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 7 | $46.13 | $323 | 17,134 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 693 | $46.13 | $32.0K | 1,798,666 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 208,712 | $45.30 | $9.45M | 1,799,359 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-10 | 2017-03-14 | 915 | $45.98 | $42.1K | 19,129 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-10 | 2017-03-14 | 96,113 | $45.98 | $4.42M | 2,008,071 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-03 | 2017-03-07 | 526 | $47.05 | $24.7K | 20,044 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-03 | 2017-03-07 | 55,246 | $47.05 | $2.60M | 2,104,184 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 3,962 | — | $0 | 3,962 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 53,909 | — | $0 | 53,909 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 5,660,377 | — | $0 | 5,660,377 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 38 | — | $0 | 38 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2016-08-24 | 2016-08-25 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-12 | 2016-08-12 | 13,967 | $33.72 | $471.0K | 2,159,430 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-12 | 2016-08-12 | 133 | $33.72 | $4.5K | 20,570 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-11 | 2016-08-12 | 1,518 | $33.63 | $51.1K | 20,703 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-11 | 2016-08-12 | 159,382 | $33.63 | $5.36M | 2,173,397 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-10 | 2016-08-12 | 116,825 | $33.77 | $3.95M | 2,332,779 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-10 | 2016-08-12 | 1,113 | $33.77 | $37.6K | 22,221 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-03 | 2016-08-05 | 420,990 | $30.59 | $12.88M | 2,449,604 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-03 | 2016-08-05 | 4,010 | $30.59 | $122.7K | 23,334 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 1,071,992 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 2,511,441 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 627,867 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 332,766 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 33,334 | $15.00 | $500.0K | 4,801,638 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 332,766 | — | $0 | 4,768,304 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 2,511,441 | — | $0 | 3,363,546 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 1,071,992 | — | $0 | 4,435,538 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 627,867 | — | $0 | 852,105 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2016-06-02 | 2016-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-11-24 | 2015-11-27 | 1,750 | — | $0 | 1,750 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-11-24 | 2015-11-27 | 650 | — | $0 | 1,259 | SEC↗ |
| GKOS GLAUKOS Corp | A Award deriv | 2015-07-23 | 2015-07-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 2,406,441 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 261 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 27,346 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 2,672 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 280,531 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,599 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 167,898 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 22,923 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 11,623 | $18.00 | $209.2K | 2,870,593 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 27,194 | — | $0 | 27,194 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 261 | — | $0 | 27,455 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 111 | $18.00 | $2.0K | 27,344 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,854,870 | — | $0 | 2,854,870 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 27,346 | — | $0 | 2,882,216 | SEC↗ |
| ROKA Roka BioScience, Inc. | A Award deriv | 2015-06-24 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 6,000 | $292.13 | $1.75M | 1,122,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 3,700 | $291.12 | $1.08M | 1,128,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 13,974 | $290.02 | $4.05M | 1,132,614 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 15,131 | $289.07 | $4.37M | 1,146,588 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 26,028 | $288.11 | $7.50M | 1,161,719 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 18,041 | $287.16 | $5.18M | 1,187,747 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 90 | $294.82 | $26.5K | 1,120,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 23,903 | $285.18 | $6.82M | 1,213,399 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 16,845 | $284.20 | $4.79M | 1,237,302 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 9,357 | $282.87 | $2.65M | 1,254,147 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 8,397 | $282.13 | $2.37M | 1,263,504 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 5,623 | $281.11 | $1.58M | 1,271,901 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 2,500 | $293.85 | $734.6K | 1,120,414 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 7,611 | $286.24 | $2.18M | 1,205,788 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-25 | 2015-03-25 | 2,800 | $270.23 | $756.6K | 1,277,524 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 6,764 | $268.13 | $1.81M | 1,319,160 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 1,539 | $269.10 | $414.1K | 1,317,621 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 3,844 | $275.56 | $1.06M | 1,280,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 12,066 | $275.00 | $3.32M | 1,284,168 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 2,700 | $273.19 | $737.6K | 1,296,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 3,050 | $272.13 | $830.0K | 1,298,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 6,063 | $271.15 | $1.64M | 1,301,984 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-24 | 2015-03-25 | 9,574 | $270.13 | $2.59M | 1,308,047 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 6,306 | $281.01 | $1.77M | 1,333,424 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,500 | $282.00 | $987.0K | 1,329,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,548 | $283.29 | $438.5K | 1,328,376 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 52 | $283.44 | $14.7K | 1,328,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,400 | $286.04 | $400.5K | 1,326,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 1,000 | $288.60 | $288.6K | 1,325,924 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 9,465 | $280.00 | $2.65M | 1,339,730 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,668 | $279.00 | $1.02M | 1,349,195 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 14,152 | $278.00 | $3.93M | 1,352,863 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 8,195 | $276.96 | $2.27M | 1,367,015 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 37,666 | $275.95 | $10.39M | 1,375,210 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 3,579 | $274.86 | $983.7K | 1,412,876 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 11,869 | $273.89 | $3.25M | 1,416,455 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 8,638 | $272.79 | $2.36M | 1,428,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 7,764 | $271.70 | $2.11M | 1,436,962 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-23 | 2015-03-25 | 40,598 | $270.70 | $10.99M | 1,444,726 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 45,058 | $300.11 | $13.52M | 1,491,124 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 400 | $302.34 | $120.9K | 1,485,324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 5,400 | $301.36 | $1.63M | 1,485,724 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-26 | 2014-08-27 | 10,400 | $299.13 | $3.11M | 1,536,182 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 12,558 | $294.67 | $3.70M | 1,584,024 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 10,010 | $296.59 | $2.97M | 1,548,572 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 25,442 | $295.52 | $7.52M | 1,558,582 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-27 | 1,990 | $297.26 | $591.5K | 1,546,582 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,254 | $294.96 | $959.8K | 1,645,156 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 4,468 | $293.85 | $1.31M | 1,648,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,704 | $292.70 | $1.08M | 1,652,878 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 350 | $308.13 | $107.8K | 1,596,582 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 14,640 | $307.06 | $4.50M | 1,596,932 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 525 | $306.23 | $160.8K | 1,611,572 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,732 | $305.14 | $528.5K | 1,612,097 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,193 | $303.77 | $362.4K | 1,613,829 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 3,985 | $300.21 | $1.20M | 1,617,832 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 7,062 | $296.21 | $2.09M | 1,638,094 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 6,192 | $296.86 | $1.84M | 1,631,902 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 9,985 | $297.76 | $2.97M | 1,621,917 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 100 | $298.61 | $29.9K | 1,621,817 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,100 | $302.55 | $332.8K | 1,615,022 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-18 | 1,710 | $301.42 | $515.4K | 1,616,122 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-09 | 2014-08-12 | 324 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-09 | 2014-08-12 | 324 | — | $0 | 609 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 38,021 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 3,992,203 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 116,981 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 12,283,019 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 56,490 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 5,931,402 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 80,715 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion deriv | 2014-07-22 | 2014-07-24 | 8,475,069 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 7,563 | — | $0 | 21,646 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy | 2014-07-22 | 2014-07-24 | 3,616 | $12.00 | $43.4K | 30,378 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy | 2014-07-22 | 2014-07-24 | 379,717 | $12.00 | $4.56M | 3,190,051 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 5,116 | — | $0 | 26,762 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 537,264 | — | $0 | 2,810,334 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 1,112,592 | — | $0 | 1,117,280 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 794,178 | — | $0 | 2,273,070 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 3,443 | — | $0 | 14,083 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 361,612 | — | $0 | 1,478,892 | SEC↗ |
| ROKA Roka BioScience, Inc. | C Conversion | 2014-07-22 | 2014-07-24 | 10,596 | — | $0 | 10,640 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-07-17 | 2014-07-21 | 348 | — | $0 | 348 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-07-17 | 2014-07-21 | 285 | — | $0 | 285 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-05-09 | 2014-05-09 | 325 | — | $0 | 324 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-05-09 | 2014-05-09 | 325 | — | $0 | 2,629 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-04-09 | 2014-04-11 | 81,305 | $320.00 | $26.02M | 1,653,629 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-02-09 | 2014-02-11 | 324 | — | $0 | 2,304 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 1,295,845 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 1,905,702 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 3,007,297 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 693,991 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 1,417,578 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 1,417,578 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 327,133 | — | $0 | 327,133 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 22,166 | $11.00 | $243.8K | 8,907,342 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 1,904,940 | — | $0 | 1,904,940 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 1,905,702 | — | $0 | 3,810,642 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 712,192 | $11.00 | $7.83M | 9,941,551 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 5,116 | $11.00 | $56.3K | 9,229,359 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 327,133 | $0.17 | $55.6K | 9,234,475 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 1,417,578 | $0.17 | $241.0K | 8,929,508 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 693,991 | — | $0 | 7,511,930 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 3,007,297 | — | $0 | 6,817,939 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 973 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-11-09 | 2013-11-12 | 325 | — | $0 | 1,980 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-21 | 2013-10-23 | 40,088 | $62.50 | $2.51M | 1,734,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2013-10-15 | 2013-10-17 | 376,585 | $62.50 | $23.54M | 1,775,022 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 1,298 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-08-09 | 2013-08-13 | 325 | — | $0 | 1,655 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-05-09 | 2013-05-09 | 324 | — | $0 | 1,623 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-05-09 | 2013-05-09 | 324 | — | $0 | 973 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-05-07 | 2013-05-09 | 1,980 | — | $0 | 1,980 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2013-05-07 | 2013-05-09 | 1,330 | — | $0 | 2,303 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2013-04-09 | 2013-04-11 | 649 | — | $0 | 1,947 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2013-04-09 | 2013-04-11 | 649 | — | $0 | 649 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 2,596 | — | $0 | 2,596 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2012-11-16 | 2012-11-20 | 11,249 | — | $0 | 11,249 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion deriv | 2012-10-16 | 2012-10-16 | 10,500,000 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy | 2012-10-16 | 2012-10-16 | 333,334 | $15.00 | $5.00M | 2,150,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | C Conversion | 2012-10-16 | 2012-10-16 | 1,817,300 | — | $0 | 1,817,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | P Buy deriv | 2012-08-09 | 2012-10-16 | 10,500,000 | $2.00 | $21.00M | 10,500,000 | SEC↗ |